Food Product for Management of Gestational Diabetes
Gestational Diabetes, Glucose Tolerance Impaired in Pregnancy, Glucose Tolerance Impaired
About this trial
This is an interventional treatment trial for Gestational Diabetes focused on measuring Wholegrain, Dietary Intervention, Gestational Diabetes, Impaired Glucose Tolerance, Insulin Sensitivity/Resistance
Eligibility Criteria
Inclusion Criteria: Pathological fasting glucose or OGTT according to WHO-criteria for the diagnosis of gestational diabetes (see Table 1). Agree to maintain consistent dietary habits and physical activity levels for the duration of the study. Willingness to complete questionnaires and follow instructions associated with the study and to perform another OGTT at the clinic in a second visit. Has given voluntary, written, informed consent to participate in the study. Exclusion Criteria: Type 2 diabetes prior to pregnancy Psychiatric Disease Acute Infections Alcohol or drug abuse Acute diverticulitis Malignant tumors or hematologic disorders Heart failure stages III-IV according to New York Heart Association (NYHA) Acute coronary syndrome Chronic kidney disease > Stage 3 (Kidney Disease Outcomes Quality Initiative - KDOQI) Celiac disease Diagnosed Inflammatory bowel diseases (mainly Crohn´s, Ulcerative colitis) Allergy to ingredients included in the investigational product. Use of antibiotics within 2 weeks of enrollment Use of probiotics within 2 weeks of enrollment
Sites / Locations
- Stoffwechselzentrum Rhein-PfalzRecruiting
Arms of the Study
Arm 1
Experimental
Study arm
Only study arm in the study. Participants consume a ready-to-eat wholegrain porridge on two consecutive evenings and repeat OGTT